Journals / Bakırköy Tıp Dergisi / 2008 / Cilt: 4 - Sayı: 1

Restless legs syndrome in patients with hemodialysis

Hemodiyaliz hastalarında huzursuz bacak sendromu

Pages
8–13
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: It is concluded that hemoglobin is an important independent factor for progression to RLS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The restless legs syndrome (RLS) is characterized by unpleasant sensations and pain in the legs, irresistible urge to move the legs, especially when resting and often accompanied by sleep disorders.
📊
Key Findings & Data:RLS prevalence is up to 80% in hemodialysis patients.
💡
Conclusion & Impact:Conclusion: It is concluded that hemoglobin is an important independent factor for progression to RLS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The restless legs syndrome (RLS) is characterized by unpleasant sensations and pain in the legs, irresistible urge to move the legs, especially when resting and often accompanied by sleep disorders. RLS prevalence is up to 80% in hemodialysis patients. It is such an important clinical condition that is associated with increased mortality. Moreover etiopathogenesis is not clear. We aimed to evaluate vascular disorders, heart rate variability, oxidative stress parameter in hemodialysis patients with RLS. Material and Methods: Study was conducted with hemodialysis patients. Twenty five patients diagnosed as RLS with International Restless Legs Study Group criteria, and twenty five patients without RLS (control group) were included to the study. Patients were examined with complete blood count and biochemical assays, Kt/V, oxidative stress parameter such as malon dialdehyde and sulphydryl, lower extremity Doppler ultrasonography and 24 hour holter heart rate variability. Results: Patients with RLS had significantly lower hemoglobin and sodium levels (p:0.025 ve p:0.038). Tibialis posterior and anterior artery flow was significantly reduced in patients with RLS (p:0.011 ve p:0.0l0). There was significant correlation about low hemoglobin and sodium level and reduced tibialis posterior and anterior artery flow. With logistic regression analysis, only hemoglobin was determined as independent factor on RLS (OR 6.211 [%95 CI 1.368-26.176] p=0.018). Conclusion: It is concluded that hemoglobin is an important independent factor for progression to RLS. Therefore hemoglobin level must be maintained in normal range especially in patients with RLS.

Özet

Amaç: Huzursuz Bacak Sendromu (HBS) özellikle istirahat sırasında ortaya çıkan bacaklarda huzursuzluk hissi, ağrı ve istem dışı bacak hareketlerine bağlı uyku bozukluklarıyla karakterize bir durumdur. Bu sendrom uzun dönem diyaliz tedavisi gören hastalarda %80'e varan oranlarda görülmekte olup artmış ölüm riskiyle ilişkili olması nedeniyle önemlidir. Bununla birlikte etyopatogenezi net olarak bilinmemektedir. Çalışmanın amacı, HBS olan hemodiyaliz hastalarında vasküler patolojileri, kalp hızı değişkenliğini ve oksidatif stres parametrelerini değerlendirmektir. Gereç ve Yöntem: Çalışma hemodiyaliz tedavisi alan hastalarla yapıldı. Çalışma grubu olarak; Uluslararası Huzursuz Bacak Çalışma Grubu'nun kriterleriyle HBS tanısı konan 25 hasta, kontrol grubu olarak; HBS olmayan 25 hasta seçildi. Hastaların rutin hemogram, biyokimya tetkikleri, Kt/V değerleri, oksidatif stres göstergeleri olan malondialdehid ve sülfidril düzeylerinin ölçümü, alt ekstremite Doppler ultrasonografi ve 24 saatlik holter (kalp hızı değişimi) tetkikleri yapıldı. Bulgular: Huzursuz bacak sendromu olanlarda anlamlı olarak; hemoglobin ve sodyum düzeyleri daha düşük idi (p:0.025 ve p:0.038). Tibialis posterior arter ve tibialis anterior arter kan akım hızlarının HBS olan grupta HBS olmayan gruba göre anlamlı olarak azalmış oldukları görüldü (p:0.011 ve p:0.010). Huzursuz bacak sendromu ile hemoglobin düzeyi düşüklüğü, sodyum düzeyi düşüklüğü, tibialis anterior arter akım hızı ve posterior arterdeki düşük akım hızları ile anlamlı bir ilişki saptandı. Bu değişkenlerden sadece hemoglobinin lojistik regresyon analizinde, HBS üzerine bağımsız etmen olduğu görüldü (OR 6.211 [%95 CI 1.368-26.176] p=0.018). Sonuç: Huzursuz bacak sendromu gelişiminde hemoglobin düzeyi bağımsız bir faktör olarak bulunmuştur. Bu nedenle özellikle HBS olan hemodiyaliz hastalarında hemoglobin düzeyi normal sınırlarda tutulmaya çalışılmalıdır.

🔖

Cite This Article

ATLI, H., ÇÖLBAY, M., DEMİR, S., YÜKSEL, Ş., USLAN, İ., ACARTÜRK, G., KARAMAN, Ö., KÖKEN, T., MELEK, M. (2008). Restless legs syndrome in patients with hemodialysis. Bakırköy Tıp Dergisi, Cilt: 4 - Sayı: 1, 8–13. https://ajindex.com/articles/131494

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Takaki J, Nishi T, Nangaku M, et al. Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney Dis 2003; 41: 833-839
  2. Kavanagrv D, Siddiqui S, Geddes CC. Restless legs syndrome in patients on dialysis. AmJ Kidney Dis 2004; 43: 763-771
  3. Bhowmik D, Bhatia M, Gupta S, Agarwal SK, Tiwari SC, Dash SC. Restless legs syndrome in hemodialysis patients in India: a case controlled study. Sleep Med 2003; 4:143-146
  4. US Renal Data System: Patient mortality and survival. Am J Kidney DİS. 1996; 28:S79-92
  5. Herzog CA. Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. Kidney Int Suppl 2003; 84: S197-200 6.Koomans HA, Blankestijn PJ, Joles JA. Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 2004; 15: 524-537. 7.Galli F, Ronco C. Oxidant stress in hemodialysis. Nephron 2000; 84: 1-5. Samouilidou EC, Grapsa EJ, Kakavas 1, Lagouranis A, Agrogiannis B. Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis. Int Urol Nephrol 2003; 35: 393-397. 9.Levin NW, Hoenich NA. Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. Curr Opin Nephrol Hypertens 2001; 10: 563-568
  6. Llach F. Hyperphosphatemia in end-stage renai disease patients: pathophysiological consequences. Kidney Int Suppl 1999; 73: S31-37
  7. Kurata C, Uehara A, Sugi T, et al. Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron 2000; 84: 312-319
  8. Köken T, Kahraman A, Serteser M, Çetinkaya G. Hemodiyalizin protein karbonil içeriği ve sülfidril grubları düzeyi üzerine etkisi. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi 2001; 10: 83-85
  9. Usberti M, Gerardi G, Bufano G, et al. Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am J Kidney Dis 2002; 40: 590-599
  10. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-1065
  11. Stiasny K, Wetter TC, Trenkwalder C, Oertel WH. Restless legs syndrome and its treatment by dopamine agonists. Parkinsonism RelatDisord 2000; 7: 21-25
  12. Walker S, Fine A, Kryger MH. Sleep complaints are common in a dialysis unit. AmJ Kidney Dis 1995; 26: 751-756.